Coremend is a research blend that combines three well-studied peptides: TB4, KPV, and BPC-157. In a research context, this combination is studied across cellular signaling, inflammatory pathways, and tissue and matrix research, where the three components overlap.
Each one is also studied on its own, and the blend lets researchers explore overlapping or complementary pathways within a single formulation (Malinda et al., 1999, FASEB Journal). That shared ground is a common reason combination peptides are used in research.
Research Applications
- Cell migration and signaling research
- Inflammatory pathway modulation studies
- Tissue and matrix research
- Multi-pathway combination research
Supplied as a lyophilized powder for stability.
See also: BPC-157, TB-500 10 mg, and BPC-157 · TB-500 (5 mg + 5 mg) (Blend).
Reviews
There are no reviews yet.